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Abstract  Rupture  of  pseudoaneurysms  is  rare  but  can  be  life-threatening  complications  of
acute or  chronic  pancreatitis,  usually  due  to  enzymatic  digestion  of  vessel  walls  crossing  peri-
pancreatic  ﬂuid  collections.  We  report  the  case  of  a  40  year-old  female,  with  multisystemic
lupus and  anticoagulated  for  prior  thrombotic  events,  admitted  for  probable  cyclosporine-
induced acute  pancreatitis.  Hemodynamic  instability  occurred  due  to  abdominal  hemorrhage
from two  pseudoaneurysms  inside  an  acute  peri-pancreatic  collection.  Selective  angiography
successfully  embolized  the  gastroduodenal  and  pancreatoduodenal  arteries.  The  hemorrhage
recurred  two  weeks  later  and  another  successful  embolization  was  performed  and  the  patient
remains well  to  date.  The  decision  to  restart  anticoagulants  and  to  suspend  cyclosporine  was
challenging  and  required  a  multidisciplinary  approach.  Despite  rare,  bleeding  from  a  pseudoa-
neurysm should  be  considered  when  facing  a  patient  with  pancreatitis  and  sudden  signs  of
hemodynamic  instability.
©  2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALAVRAS-CHAVE Pancreatite  Aguda  Medicamentosa  e  Pseudoaneurismas:  Uma  Combinac¸ão  Tenebrosa
Falso  Aneurisma;
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Resumo  Os  pseudoaneurismas  são  complicac¸ões  raras  mas  graves  da  pancreatite  aguda  ou
crónica. São  causados  pela  digestão  enzimática  de  artérias  que  atravessam  colecc¸ões  inﬂa-
matórias.  Descreve-se  o  caso  de  uma  doente  do  sexo  feminino,  de  40  anos,  com  lúpus  sistémico
ose  venosa  profunda,  admitida  por  pancreatite  aguda  associada  à
nais  de  hemorragia  abdominal  causada  por  dois  pseudoaneurismasquimicamente e anticoagulada  por  tromb
ciclosporina.  Apresentou  si∗ Corresponding author.
E-mail address: diogofbranquinho@yahoo.com (D. Branquinho).
http://dx.doi.org/10.1016/j.jpge.2016.06.002
2341-4545/© 2016 Sociedade Portuguesa de Gastrenterologia. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dentro  de  uma  colecc¸ão  peri-pancreática.  Foi  então  realizada  angiograﬁa  com  embolizac¸ão  da
artéria gastroduodenal  e  pancreatoduodenal.  Houve  recidiva  duas  semanas  depois,  com  neces-
sidade de  nova  embolizac¸ão  bem-sucedida.  A  decisão  de  suspender  a  ciclosporina  e  reintroduzir
anticoagulantes  nesta  doente  de  alto-risco  é  controversa.  Apesar  de  raros,  os  pseudoaneurismas
devem  ser  considerados  perante  um  doente  com  pancreatite  e  sinais  de  hemorragia.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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was  conducted  revealing  a  peripancreatic  acute  ﬂuid  col-. Introduction
ost  cases  of  pancreatitis  are  mild  and  have  a  favor-
ble  prognosis.  However  they  can  also  be  present  with
 severe  form  and  have  ominous  complications.  Vascu-
ar  events  range  from  asymptomatic  venous  thrombosis  to
evere  life-threatening  arterial  bleeding.1 Hemorrhage  from
seudoaneurysms  is  considered  a  quite  rare  complication
f  acute  or  more  commonly  chronic  pancreatitis,  which  is
hought  to  be  caused  by  leakage  of  pancreatic  enzymes
hat  erode  the  wall  of  adjacent  visceral  arteries.  The  ves-
el  wall  may  also  be  damaged  by  ischemia  and  compression
y  inﬂammatory  or  necrotic  collections.  A  pseudoaneurysm
ay  also  occur  after  biliopancreatic  surgery.2 The  most  fre-
uently  involved  vessels  are  the  splenic  artery  in  about
0--60%,  the  gastroduodenal  artery  in  20--25%  and  the
ancreatoduodenal  artery  in  10--15%  of  the  cases.  Involve-
ent  of  the  hepatic  or  left  gastric  arteries  is  even  less
ommon.3 Bleeding  may  occur  into  the  gastrointestinal  tract
nd  present  as  melena  or  hematochezia  through  the  main
ancreatic  duct  (hemosuccus  pancreaticus), into  a  pseudo-
yst/peripancreatic  collection  or  into  the  peritoneal  cavity.
seudoaneurysm  hemorrhage  may  occur  from  a  few  days  to
everal  years  after  the  onset  of  pancreatitis.4
When  this  diagnosis  is  suspected,  contrast-enhanced  CT
ngiography  is  an  excellent  modality  for  identifying  and
ocating  the  pseudoaneurysm  as  well  as  it  can  demonstrate
eatures  of  chronic  pancreatitis.  It  may  show  simultaneous
paciﬁcation  of  an  aneurysmal  artery  and  pseudocyst  or  pen-
tration  of  contrast  within  a  pseudocyst  after  the  arterial
hase.5 This  is  necessary  for  subsequent  selective  angiog-
aphy,  the  gold  standard  method  for  deﬁnitive  diagnosis
nd  treatment  of  pseudoaneurysms.  Proximal  embolization
ith  coils  is  the  preferred  technique  and  has  replaced  sur-
ical  ligation  of  the  damaged  artery  as  the  best  method
or  treatment.6 Injection  of  a  haemostatic  gelatin  sponge
spongostan®),  cyanoacrylate,  thrombin  or  placement  of
overed  stents  may  also  be  useful.  Published  case  series
nclude  a  relatively  low  number  of  cases,  but  show  that
mbolization  is  a  safe  method  with  high  success  rate  and
elatively  low  risk  of  recurrence  or  ischemia.7,8 To  the  best
f  our  knowledge,  there  is  only  one  other  case  report  of
 pseudoaneurysm  complicating  a  probable  drug-induced
cute  pancreatitis.3
According  to  Badalov  classiﬁcation,9 cyclosporine  is
 class  III  drug  concerning  the  risk  of  inducing  acute
l
c
wancreatitis,  which  means  that  there  are  at  least  two  known
ases  in  medical  literature,  but  with  no  consistent  latency
ime  between  exposure  to  the  drug  and  ensuing  symptoms
r  evidence  of  positive  rechallenge.  Those  cases  occurred
n  post-transplant  setting.10 Despite  the  paucity  of  clini-
al  reports  about  cyclosporine-induced  acute  pancreatitis,
here  is  an  experimental  model  that  suggests  a  deleterious
ole  for  the  drug  in  pancreas  transplant  recipients,  causing
ancreatitis  more  often  than  tacrolimus.11 Since  rechallenge
s  not  an  option  due  to  obvious  medical  and  ethical  concerns,
iagnosis  of  drug-induced  pancreatitis  relies  on  careful  his-
ory  taking  and  high  index  of  suspicion.
. Case report
e  present  the  case  of  a  40  year-old  female  patient  with
 medical  history  of  severe  systemic  lupus  erythemato-
us  (SLE)  and  secondary  anti-phospholipidic  syndrome,  with
ast  episodes  of  venous  thrombosis  (pulmonary  and  deep
enous  thrombosis  in  2008)  that  led  to  placement  of  a  ﬁl-
er  in  the  inferior  vena  cava  and  in  the  right  iliac  vein.
he  patient  was  anticoagulated  with  warfarin.  She  was
lso  taking  prednisolone,  hydroxychloroquine,  ramipril,  ser-
raline  and  alprazolam.  Due  to  lupus  reactivation,  she
as  recently  medicated  with  cyclosporine.  There  was  no
istory  of  alcohol  consumption,  familial  history  of  pancre-
titis,  cholelithiasis  or  hypertriglyceridemia.  There  were
lso  no  previous  endoscopic  or  surgical  abdominal  inter-
entions.  Two  weeks  after  being  prescribed  with  150  mg
f  cyclosporine,  she  was  admitted  to  the  emergency  room
ith  acute  epigastric  abdominal  pain  with  lumbar  irradi-
tion,  fever,  nausea  and  vomiting  that  started  four  days
efore  admission.  Elevated  levels  of  amylase  and  lipase
more  than  three  times  above  the  upper  normal  limit)  sup-
orted  the  diagnosis  of  acute  pancreatitis.  There  were  no
anson  criteria  at  admission,  BISAP  score  (bedside  index
or  severity  in  acute  pancreatitis)  was  zero  and  there  were
o  signs  of  organ  failure  or  SIRS  (systemic  inﬂammatory
esponse  syndrome).  Three  days  after  admission,  the  patient
uffered  a  lipothymia  and  a  brisk  fall  in  her  hemoglobin  lev-
ls  was  noticed  (from  119  g/L  to  64  g/L).  An  abdominal  CTection  with  active  bleeding  within  (Figs.  1  and  2).  The
ollection  developed  about  a  week  after  disease  onset.  It
as  located  close  to  the  bifurcation  of  the  gastroduodenal
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Figure  1  Peripancreatic  collection  with  spontaneously  hyper-
dense  content  suggestive  of  hematoma  (arrows)  (abdominal  CT,
before  contrast  administration).
Figure  2  Pseudoaneurysm  with  active  bleeding  (triangle)
Figure  3  Saccular  pseudoaneurysm  in  the  gastroduodenal
artery  (arrow)  before  embolization  was  performed  (ﬁrst  angiog-
raphy).
Figure  4  Embolization  with  two  coils  in  the  gastroduodenal
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twithin the  peripancreatic  collection  (arrows)  (abdominal  CT,
arterial phase,  maximum  intensity  projection  reformation).
artery  into  the  right  gastroepiploic  artery  and  the  ante-
rior  superior  pancreaticoduodenal  artery.  The  patient  was
transferred  to  our  center  for  an  angiography  of  the  celiac
trunk  and  superior  mesenteric  artery.  Two  pseudoaneurysms
in  the  gastroduodenal  and  pancreatoduodenal  arteries  with
active  bleeding  were  diagnosed  and  successfully  embolized
with  two  coils  (Figs.  3  and  4).  The  procedure  was  success-
ful  and  there  were  no  signs  of  iatrogenic  regional  ischemia,
which  could  occur  due  to  limited  blood  supply  caused  by
the  embolization.  Initially,  the  patient  was  unstable,  but  her
hemodynamic  status  improved  with  adequate  ﬂuid  resusci-
tation,  fresh  plasma  and  packed  red  blood  cells  transfusion.
After  controlling  the  hemorrhage,  it  was  decided  to  imme-
diately  restart  anticoagulation,  given  the  major  risk  of
thrombosis  in  a  patient  with  phospholipidic  syndrome  and
a  ﬁlter  in  the  inferior  vena  cava.  The  following  week  was
uneventful  and  the  patient  was  discharged  and  told  to
maintain  the  same  medication,  including  cyclosporine  and
enoxaparin.  About  one  week  after  being  discharged,  the
patient  had  a  recrudescence  of  the  abdominal  pain  and  was
again  admitted  to  her  local  hospital.  In  the  following  day,
a  new  sudden  fall  in  hemoglobin  levels  occurred  (123  g/L
o
s
d
lrtery  (blue  arrow)  and  in  a  branch  of  the  superior  mesenteric
rtery  (red  arrow)  (ﬁrst  angiography).
o  48  g/L)  and  a second  angiography  was  performed.  Again
here  were  signs  of  active  bleeding  into  the  peripancre-
tic  collection  and  the  gastroduodenal  artery  was  embolized
ith  a  third  coil  (Figs.  5  and  6).  The  procedure  was  successful
nd  there  was  a  favorable  evolution  with  no  signs  of  hem-
rrhage  until  discharge.  After  consulting  with  the  patient’s
heumatologist,  it  was  decided  to  stop  cyclosporine  as  it
robably  caused  the  pancreatitis.  Until  this  date,  the  patient
emains  well  and  without  further  complications.
.  Discussion
everal  issues  regarding  this  case  merit  careful  analysis.
irst,  the  etiology  of  the  pancreatitis  should  be  discussed.
fter  a  thorough  medical  history,  most  causes  of  pancreati-
is  were  excluded.  The  patient  had  no  history  of  alcoholism
r  smoking,  recent  acute  illness,  abdominal  trauma  or
urgery.  There  was  no  familial  history  of  pancreatitis.  She
enied  complaints  of  long-standing  abdominal  pain,  weight
oss  or  steatorrhea  that  could  suggest  chronic  pancreatitis.
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Figure  5  Recurrence  of  bleeding  from  the  gastroduodenal
artery  (arrow)  (second  angiography).
Figure  6  A  third  coil  was  inserted  in  the  gastroduodenal
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Krtery with  successful  embolization  of  this  vessel  (green  arrow)
second  angiography).
aboratory  analysis  excluded  hypertriglyceridemia  and
ypercalcemia  as  potential  causes  as  well.  There  was  no
levation  of  hepatic  enzymes  or  bile  duct  dilation  suggestive
f  microlithiasis.  Abdominal  ultrasound  and  CT  scan  showed
o  signs  of  cholelithiasis,  bilio-pancreatic  lesions  or  chronic
ancreatitis  (CP).  However,  in  early  stage  CP,  imaging
ethods  may  show  only  minimal  changes.  Endoscopic
ltrasonography  (EUS)  has  been  shown  to  be  highly  accurate
or  the  identiﬁcation  of  gallbladder  sludge/microlithiasis,
ommon  bile  duct  stones,  and  pancreatic  diseases  (pan-
reatic  neoplasms  and  chronic  pancreatitis)12 and  would  be
seful  to  exclude  these  diagnoses  in  our  patient.  In  patients
onsidered  to  have  idiopathic  acute  pancreatitis,  after
egative  initial  work-up  for  biliary  etiology,  EUS  is  recom-
ended  as  the  ﬁrst  step  to  assess  for  occult  microlithiasis,
eoplasms  and  chronic  pancreatitis.13Concerning  medication,  only  cyclosporine  was  recently
ntroduced.  Prednisolone  and  ramipril  are  also  potential
gents  of  drug-induced  acute  pancreatitis.  However,  the
atient  was  taking  these  medications  for  over  three  years.
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he  remaining  medication  (warfarin,  hydroxochloroquine,
ertraline  and  alprazolam)  were  also  prescribed  a  few  years
efore  this  episode.  It  seems  more  likely  that  cyclosporine
as  the  culprit  due  to  the  short  lapse  of  time  between
tarting  this  medication  and  the  beginning  of  clinical  man-
festations.  This  is  consistent  to  what  is  described  in  one
f  the  case  reports  of  cyclosporine-induced  pancreatitis.
his  supports  our  hypothesis  as  consistent  latency  time
mong  cases  is  one  of  the  criteria  suggested  in  Badalov
lassiﬁcation.9 Drug-induced  acute  pancreatitis  is  a  rare
ntity,  difﬁcult  to  diagnose  since  it  has  no  distinguishing
linical  features.  Several  distinct  mechanisms  were  sug-
ested  and  include  direct  toxic  effect  (such  as  furosemide),
mmunologic  reaction  (with  6-mercaptopurine  or  aminosali-
ylates),  ischemia  (for  azathioprine),  increased  viscosity  of
ancreatic  ﬂuids  (e.g.,  corticosteroids)  intravascular  throm-
osis  (with  estrogens)  or  accumulation  of  a  toxic  metabolite
drugs  such  as  valproic  acid  or  tetracyclines).14 Due  to  this
ariety  of  causative  mechanisms,  the  time  between  expo-
ure  to  the  drug  and  initial  symptoms  may  be  as  short
s  a  few  days  for  immunologic  reactions  or  even  several
onths  if  there  is  slow  accumulation  of  toxins.  There  was
o  eosinophilia  or  skin  rash,  but  these  ﬁndings  are  seldom
ound  in  such  cases.
Another  possible  etiology  for  this  episode  is  lupus  pan-
reatitis.  It  is  a  quite  rare  and  ill-deﬁned  entity.  It  has  no
peciﬁc  diagnostic  criteria  and  it  usually  occurs  during  a
are  of  SLE.  Usually  its  treatment  is  based  in  high-dose
orticosteroids.15 The  patient  recently  had  a ﬂare  of  SLE.
owever,  her  full  recovery  from  it  and  being  medicated
ith  a  potent  immunosuppressive  agent  like  cyclosporine
nd  a  low  dose  of  corticosteroids  argue  against  this  diagno-
is.  Furthermore,  according  to  the  patient’s  Rheumatologist,
here  were  no  signs  of  a  new  SLE  ﬂare  when  the  pancreatitis
ccurred  --  absence  of  cytopenias,  rash,  renal  or  neurologi-
al  abnormalities.  Due  to  the  quiescent  status  of  SLE,  it  was
onsidered  relatively  safe  to  suspend  cyclosporine.  The  risk
f  a  new  episode  of  pancreatitis  and  hemorrhage  was  con-
idered  more  signiﬁcant  and  life-threatening  than  the  risk
f  a  new  ﬂare  of  SLE.
Another  pertinent  clinical  issue  was  the  decision  to  rein-
tate  anticoagulation.  When  peritoneal  hemorrhage  was  ﬁrst
uspected,  anticoagulation  was  suspended  but  after  the  ﬁrst
mbolization,  it  was  decided  to  restart  it  a  few  hours  later.
he  recurrence  of  the  hemorrhage  was  probably  bolstered
y  this  decision.  However,  given  the  very  high  risk  of  throm-
osis  due  to  the  phospholipidic  syndrome  and  two  vascular
lters,  it  would  be  at  least  equally  risky  not  to  restart
nticoagulation.  In  these  high-risk  patients,  the  decision  to
uspend  or  restart  anticoagulation  should  be  made  in  a  case-
y-case  basis.  In  our  patient’s  case,  the  ﬁrst  angiography  was
uccessful  and  there  were  apparently  no  technical  issues
hat  could  have  contributed  to  the  rebleeding  episode.
here  is  probably  no  advantage  in  switching  to  the  new
ral  anticoagulants  (NOACs),  as  their  risk  of  gastrointesti-
al  or  abdominal  bleeding  is  at  least  similar  to  older  vitamin
 antagonists.16
Both  angiographies  were  life-saving  procedures  for  our
atient.  This  case  highlights  the  importance  of  having  a
4-hour  interventional  radiology  team  on  call  with  exper-
ise  in  these  procedures.  When  available,  angiography  with
mbolization  is  usually  the  preferred  method  to  perform
11
1
1
1
1
1
BMJ. 2015;350:1857.Drug-induced  acute  pancreatitis  and  pseudoaneurysms  
hemostasis.  Its  success  rates  are  high  but  rebleeding  is  not
an  uncommon  event  (up  to  19--23%).17 Surgery  remains  an
important  treatment  modality  especially  in  massive  bleed-
ing,  after  embolization  or  stenting  failure  or  for  treatment
of  the  underlying  condition  (e.g.,  bleeding  from  a  post-
operative  pseudoaneurysm).
In  conclusion,  when  evaluating  a  patient  admitted  for  an
acute  pancreatitis  with  a  severe  gastrointestinal  bleeding,
hemoperitoneum  or  hemodynamic  instability,  hemorrhage
from  a  pseudoaneurysm  should  be  suspected  and  immedi-
ately  treated  if  present.  To  the  best  of  our  knowledge,  this
is  only  the  second  described  case  of  hemorrhage  from  a
pseudoaneurysm  after  drug-induced  acute  pancreatitis.
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